An Innovative Low Energy Method for Cooling Dispensed Drinks
An Innovative Low Energy Method for Cooling Dispensed Drinks
批准号:
130929
负责人:
金额:
$3.19万
依托单位:
依托单位国家:
英国
项目类别:
Feasibility Studies
财政年份:
2012
资助国家:
英国
项目状态:
已结题
起止时间:
2012 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Brewfitt are a family company that have served the drink industry across the world for over 50 years. They are the UK's leading supplier to pubs and bars and have, since they invented the first drinks cooling system, had to constantly innovate to provide better products and services and stay ahead of the competition. In this project they are responding to increasing demand for diversity in pubs and bars whilst reducing environmental and financial costs and product wastage.The temperature at which a drink is served is crucial to to its success, but the technology that is in place to deliver temperature range needed is over half a century old. There are currently over 40, 000 drinks cellars in the UK each of which employs ineffcient cooling systems that constantly consume 4kw. Drinks are pumped substantial distances to the bar during which they warm up and waste further energy. At the bar, drinks are further cooled to drinking temperature by additional, 1kW coolers. In addition to this drink also accumulates in long pipe runs resulting in a typical wastage of 20 litres a week, or, over a 1,000 litre a year.Brewfitt have invented an innovative new, cooling system that is far more efficient system - based upon a highly compact heat exchanger - that can cool drinks on demand, at the point of dispense. This system could potentially save up to 75% of the cooling costs of an outlet resulting in savings of approximately £100m, 100’s of millions of tonnes of CO2 and 40 million litres of drinks in the UK alone.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
骨髓微环境中正常造血干/祖细胞新亚群IL7Rα(-)LSK(low)细胞延缓急性髓系白血病进程的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王震毅
-
依托单位:
MSCEN聚集体抑制CD127low单核细胞铜死亡治疗SLE 的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:耿林玉
-
依托单位:
新型PDL1+CXCR2low中性粒细胞在脉络膜新生血管中的作用及机制研究
-
批准号:82271095
-
项目类别:面上项目
-
资助金额:56万元
-
批准年份:2022
-
负责人:柳夏林
-
依托单位:
CD9+CD55low脂肪前体细胞介导高脂诱导脂肪组织炎症和2型糖尿病的作用和机制研究
-
批准号:82270883
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:毕艳
-
依托单位:
CD21low/-CD23-B细胞亚群在间质干细胞治疗慢性移植物抗宿主病中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:陈小湧
-
依托单位:
探究Msi1+Lgr5neg/low肠道干细胞抵抗辐射并驱动肠上皮再生的新机制
-
批准号:82270588
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:吕聪
-
依托单位:
m6A去甲基化酶FTO通过稳定BRD9介导表观重塑在HIF2α(low/-)肾透明细胞癌中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54.7万元
-
批准年份:2021
-
负责人:徐丹枫
-
依托单位:
circEFEMP1招募PRC2促进HOXA6启动子组蛋白甲基化修饰调控Claudin4-Low型TNBC迁移侵袭和转移的作用机制
-
批准号:82002807
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:韩晔
-
依托单位:
上皮间质转化在Numb-/low前列腺癌细胞雄激素非依赖性中的作用及机制
-
批准号:82003061
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:郭艳靓
-
依托单位:
Bach2调控CD45RA-Foxp3low T细胞影响B细胞功能及其在系统性红斑狼疮中作用的机制研究
-
批准号:81873863
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:郑英霞
-
依托单位: